Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 158-165

Karger

Access to resources Recommend Favorite

Initial assessment of a novel delivery system (NuDEL^{™ ®}) for the covered Cheatham-Platinum stent

By  

Cardiology in the Young, Vol. 27, Iss. 8, 2017-06 ,pp. : 1465-1469

Cambridge University Press

Access to resources Recommend Favorite

Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy

By Mohanty Chandana   Acharya Sarbari   Mohanty Anjan K   Dilnawaz Fahima   Sahoo Sanjeeb K  

Nanomedicine, Vol. 5, Iss. 3, 2010-04 ,pp. : 433-449

Future Medicine

Access to resources Recommend Favorite

Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer

By  

Case Reports in Oncology, Vol. 2, Iss. 3, 2009-09 ,pp. : 168-171

Karger

Access to resources Recommend Favorite

Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy

By  

Oncology Research and Treatment, Vol. 35, Iss. 10, 2012-09 ,pp. : 576-580

Karger

Access to resources Recommend Favorite